Cargando…

The Rationale for Post-Operative Radiation in Localized Bladder Cancer

Local-regional recurrence for patients with ≥pT3 disease after radical cystectomy is a significant problem. Chemotherapy has not been shown to reduce the risk of local-regional recurrences in randomized prospective trials, and salvage therapies for local-regional failure are rarely successful. There...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baumann, Brian C., Sargos, Paul, Eapen, Libni J., Efstathiou, Jason A., Choudhury, Ananya, Bahl, Amit, Murthy, Vedang, Ballas, Leslie K., Fonteyne, Valérie, Richaud, Pierre M., Zaghloul, Mohamed S., Christodouleas, John P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271478/ https://www.ncbi.nlm.nih.gov/pubmed/28149931 http://dx.doi.org/10.3233/BLC-160081

Ejemplares similares

Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
por: Sargos, Paul, et al.
Publicado: (2016)

Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
por: Baumann, Brian C., et al.
Publicado: (2021)

Dose-escalation of radiation may improve outcomes of squamous cell carcinoma of bladder
por: Karmakar, Shreyasee, et al.
Publicado: (2019)

Radiovaccination Hypothesis
por: Eapen, Libni
Publicado: (2017)

A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
por: Portner, R., et al.
Publicado: (2021)

Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2021)

Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?
por: Lewis, Shirley, et al.
Publicado: (2017)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
por: Ballas, Marc S, et al.
Publicado: (2011)

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
por: Orré, Mathieu, et al.
Publicado: (2017)

Editorial: Post Operative Radiation Treatment for Prostate Cancer
por: Latorzeff, I., et al.
Publicado: (2022)

Selecting candidates for early discharge after radical cystectomy for bladder cancer
por: Fonteyne, Valérie, et al.
Publicado: (2018)

Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder
por: Decaestecker, Karel, et al.
Publicado: (2017)

Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle‐invasive bladder cancer
por: Krishnatry, Rahul, et al.
Publicado: (2023)

Metastatic Bladder Cancer: A Review of Current Management
por: Fletcher, Andrew, et al.
Publicado: (2011)

Immunotherapy and Radiation – A New Combined Treatment Approach for Bladder Cancer?
por: Buchwald, Zachary S., et al.
Publicado: (2015)

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2018)

Exploring trends in advanced bladder cancer using the NCDB: turning data into information and information into insight
por: Thiruthaneeswaran, Niluja, et al.
Publicado: (2018)

Rationale for an early detection program for bladder cancer
por: Khochikar, Makarand V.
Publicado: (2011)

Radiomics-guided therapy for bladder cancer: Using an optimal biomarker approach to determine extent of bladder cancer invasion from t2-weighted magnetic resonance images
por: Tong, Yubing, et al.
Publicado: (2018)

Primary CNS Extranodal Marginal Zone B-Cell Lymphoma: A Case Series of 2 Patients Treated with External Beam Radiation Therapy
por: Ariani, Rojine, et al.
Publicado: (2021)

Rationale and design of the validation of bladder health instrument for evaluation in women (VIEW) protocol
por: Lukacz, Emily S., et al.
Publicado: (2021)

Comprehensive Analysis of Low Molecular Weight Serum Proteome Enrichment for Mass Spectrometric Studies
por: Das, Lipi, et al.
Publicado: (2020)

Primary Burkitt lymphoma of the supraglottic larynx: a case report and review of the literature
por: Quimby, Alexandra E., et al.
Publicado: (2017)

The Promise of Magnetic Resonance Imaging in Radiation Oncology Practice in the Management of Brain, Prostate, and GI Malignancies
por: Srinivasan, Shashank, et al.
Publicado: (2022)

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer
por: Fischer‐Valuck, Benjamin W., et al.
Publicado: (2019)

Disparities in male versus female oncologic outcomes following bladder preservation: A population‐based cohort study
por: Ballas, Leslie K., et al.
Publicado: (2021)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Indigenous Groin Board Immobilization Reduces Planning Target Volume Margins in Groin Radiotherapy
por: Krishnatry, Rahul, et al.
Publicado: (2021)

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
por: Fonteyne, Valérie, et al.
Publicado: (2017)

The effect of hypoxia on PD-L1 expression in bladder cancer
por: Smith, Vicky, et al.
Publicado: (2021)

2371 Validation of a novel PD-L1 assay for bladder cancer circulating tumor cells
por: Seranio, Nicolas, et al.
Publicado: (2018)

Rationale for the Use of Prostaglandins and Phosphodiesterase Inhibitors in the Treatment of Functional Bladder Disorders
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2013)

Salivary IgA as a Surrogate Biomarker for Microbial Infections in Postoperative Patients Receiving Chemo-Radio-Therapy for Head and Neck Cancer
por: Chavan, Preeti, et al.
Publicado: (2023)

The Case for Clinical Pathways in Radiation Oncology
por: Christodouleas, John, et al.
Publicado: (2013)

Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol
por: Rammant, Elke, et al.
Publicado: (2017)

Stone in the Bladder—Operations for
por: Cunningham, J. A.
Publicado: (1900)

Perioperative rehabilitation in operation for lung cancer (PROLUCA) – rationale and design
por: Sommer, Maja S, et al.
Publicado: (2014)

Analysis of variants in DNA damage signalling genes in bladder cancer
por: Choudhury, Ananya, et al.
Publicado: (2008)

Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response
por: Daro-Faye, Mame, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m1hiua49e0afa9kv1iht6tmlce